Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2003-10-28 | David S. Barlow, has served as a director of the Company since June 1999. Since March 2000 Mr. Barlow has served as Chairman of Molecular Insight Pharmaceuticals, Inc. and as Chief Executive Officer since December 2002. Mr. Barlow has also served as President of Black Diamond Capital, a private investment company, since October 1999. |
Data sourced from SEC filings. Last updated: 2025-07-01